Cargando…

Assessment of background levels of autoantibodies as a prognostic marker for severe SARS-CoV-2 infection

BACKGROUND: Patients with more severe forms of SARS-CoV-2 exhibit activation of immunological cascades. Participants (current or ex-smokers with at least 20 years pack history) in a trial (Early Diagnosis of Lung Cancer, Scotland [ECLS]) of autoantibody detection to predict lung cancer risk had seve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sullivan, Frank M., Tello, Agnes, Rauchhaus, Petra, Santiago, Virginia Hernandez, Daly, Fergus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AboutScience 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069225/ https://www.ncbi.nlm.nih.gov/pubmed/35517714 http://dx.doi.org/10.33393/jcb.2022.2337

Ejemplares similares

Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging
por: Sullivan, Frank M., et al.
Publicado: (2021)

Autoantibodies in Rheumatoid Arthritis: Historical Background and Novel Findings
por: Sokolova, Maria V., et al.
Publicado: (2021)

Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection
por: Chen, Catherine, et al.
Publicado: (2021)

SARS-CoV-2 serological cross-reactivity with autoantibodies
por: Choy, Kay Weng
Publicado: (2021)

Paradoxical sex-specific patterns of autoantibody response to SARS-CoV-2 infection
por: Liu, Yunxian, et al.
Publicado: (2021)

AngII autoantibodies after SARS-CoV-2 infection
por: Wang, Monica
Publicado: (2022)

Angiotensin System Autoantibodies Correlate With Routine Prognostic Indicators for COVID-19 Severity
por: Labandeira, Carmen M., et al.
Publicado: (2022)

Prognostic factors for the severity of SARS-CoV-2 infection
por: Rubio-Sánchez, Ricardo, et al.
Publicado: (2021)

SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply
por: Teng, Jialin, et al.
Publicado: (2021)

Why Does SARS-CoV-2 Infection Induce Autoantibody Production?
por: Macela, Ales, et al.
Publicado: (2021)

Development of ACE2 autoantibodies after SARS-CoV-2 infection
por: Arthur, John M., et al.
Publicado: (2021)

Assessment of tryptophan and kynurenine as prognostic markers in patients with SARS-CoV-2
por: Michaelis, Simon, et al.
Publicado: (2022)

Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course
por: Muri, Jonathan, et al.
Publicado: (2023)

Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies
por: Damoiseaux, Jan, et al.
Publicado: (2022)

Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation
por: Darmarajan, Thiviya, et al.
Publicado: (2022)

SARS-CoV-2 infection is associated with anti-desmoglein 2 autoantibody detection
por: Ward, Kerensa E, et al.
Publicado: (2023)

Prognostic markers for the clinical course in the blood of patients with SARS-CoV-2 infection
por: Fischer, Johannes C., et al.
Publicado: (2022)

Tumor-associated autoantibodies as diagnostic and prognostic biomarkers
por: Heo, Chang-Kyu, et al.
Publicado: (2012)

New-Onset Graves’ Disease in the Background of Hashimoto’s Thyroiditis: Spectrums of the Same Disease With Changing Autoantibodies
por: Arshad, Iqra, et al.
Publicado: (2022)

Could the Biogeographic Background Affect the Emergence of SARS-CoV-2 Variants?
por: Akaishi, Tetsuya
Publicado: (2022)

A Unique Set of Symptoms in the Background of SARS-CoV-2 Infection
por: Hamid, Muhammad Ammar B, et al.
Publicado: (2021)

Disease‐duration based comparison of subsets of immune cells in SARS CoV‐2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity
por: Kulkarni‐Munje, Archana, et al.
Publicado: (2021)

Recruitment and retention in a multicentre randomised controlled trial in Bell's palsy: A case study
por: McKinstry, Brian, et al.
Publicado: (2007)

SARS-CoV-2 infection induces cross-reactive autoantibodies against angiotensin II
por: Briquez, Priscilla S., et al.
Publicado: (2021)

Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals
por: Lingel, Holger, et al.
Publicado: (2021)

SARS-CoV-2 Vaccine Response in Patients With Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
por: Floyd, Lauren, et al.
Publicado: (2021)

Cytokine autoantibodies in SARS-CoV-2 prepandemic and intrapandemic samples from an SLE cohort
por: Choi, May Y, et al.
Publicado: (2022)

Autoantibodies are highly prevalent in non–SARS-CoV-2 respiratory infections and critical illness
por: Feng, Allan, et al.
Publicado: (2023)

Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS
por: Salton, Francesco, et al.
Publicado: (2022)

Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections
por: Bénard, Alan, et al.
Publicado: (2021)

Autoantibodies as Diagnostic Markers and Mediator of Joint Inflammation in Arthritis
por: Fang, Qinghua, et al.
Publicado: (2019)

Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis
por: Marzęcka, Milena, et al.
Publicado: (2022)

Open-string T-duality and applications to non-geometric backgrounds
por: Cordonier-Tello, Fabrizio, et al.
Publicado: (2018)

Spontaneous serum autoantibody fluctuations: To be or not to be
por: Ehrenreich, Hannelore, et al.
Publicado: (2020)

Combining Propensity Score and Random Coefficient Modelling as an Approach to Analyse Complex Longitudinal Data
por: Clos, Stefan, et al.
Publicado: (2017)

Prognostic impact of CT severity score in childhood cancer with SARS-CoV-2
por: Romeih, Marwa, et al.
Publicado: (2021)

No anti-ACTH autoantibody in serum of SARS patients
por: Li, Jing, et al.
Publicado: (2006)

Rise and exacerbation of oral lichen planus in the background of SARS-CoV-2 infection
por: Sood, Anubhuti, et al.
Publicado: (2021)

Autoantibodies elicited with SARS-CoV-2 infection are linked to alterations in double negative B cells
por: Castleman, Moriah J., et al.
Publicado: (2022)

Background, testing methods, and laboratory approaches to sars coronavirus-2 (SARS-CoV-2) and covid19
por: Rawlinson, William D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_df0mnkci6mhjo6hhep7bpk1eg2